Clinical trialNCT03013998RecruitingPhase 1/PHASE2Interventional

Study of Biomarker-Based Treatment of Acute Myeloid Leukemia

SponsorBeat AML, LLCEnrollment3,000Previously Untreated Relapsed Refractory Acute Myeloid Leukemia

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

John C Byrd, MD
Beat AML
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Mayo Clinic Arizona
Phoenix, Arizona, United States
Completed
Ucla Ronald Reagan Medical Center
Los Angeles, California, United States
Gary Schiller, MD
Recruiting
University of California, San Francisco
San Francisco, California, United States
Rebecca Olin, MD
Recruiting
University of Colorado
Denver, Colorado, United States
Completed
University of Florida Health Shands Cancer Hospital
Gainesville, Florida, United States
Completed
Mayo Clinic Florida
Jacksonville, Florida, United States
Completed
Emory University
Atlanta, Georgia, United States
William Blum, MD
Recruiting
University of Chicago
Chicago, Illinois, United States
Wendy Stock, MD
Recruiting
University of Kansas Clinical Research Center
Fairway, Kansas, United States
Tara Lin, MD
Recruiting
University of Maryland Medical Center
Baltimore, Maryland, United States
Maria Baer, MD
Recruiting
Mayo Clinic Minnesota
Rochester, Minnesota, United States
Completed
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Eytan M Stein, MD
Recruiting
Unc Hospitals, University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States
Joshua Zeidner, MD
Recruiting
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Emily Curran, MD
Recruiting
Ohio State University
Columbus, Ohio, United States
Shivani Handa, MD
Recruiting
Oregon Health & Science University
Portland, Oregon, United States
Ronan Swords, MD
Recruiting
Upmc Hillman Cancer Center
Pittsburgh, Pennsylvania, United States
Robert Redner, MD
Not, yet, recruiting
University of Texas Southwestern
Dallas, Texas, United States
Yazan Madanat, MD
Recruiting
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Completed

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Nov 2016
Primary completion: 31 Dec 2028
Completion: 31 Dec 2028
Last update posted: 17 Dec 2025
Registered enrollment: 3,000
Registry id: NCT03013998

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.